Multifunctional CoFcMOF Nanozyme Facilitates a Self-Validating Triple-Modal Immunosensor for CRP in Serum and...

Accurate quantification of C-reactive protein (CRP) in serum and synovial fluid is critical for diagnosing and monitoring localized inflammatory arthritis, but it remains challenging due to the complexity of the matrix and the lack of robust and sensitive assays. To overcome this critical challenge, a novel self-validating triple-modal immunosensing platform was developed based on a rationally designed multifunctional cobalt-ferrocene metal-organic framework (CoFcMOF) nanozyme, which ensures robust detection reliability through a synergistic signal fusion mechanism. The innovation lies in the "three-in-one" nanolabel of CoFcMOF that concurrently serves as a peroxidase (POD) mimic for colorimetric readout, an efficient quencher for the electrochemiluminescence (ECL) of carboxylated graphitic carbon nitride (C-g-C₃N₄), and a bioconjugation tag that amplifies the electrochemical impedance spectroscopy (EIS) signal upon immunocomplex formation. Critically, all three mechanistically distinct yet intrinsically linked signaling pathways are intrinsically triggered by a single biorecognition event, enabling real-time and built-in cross-validation. This cooperative design affords exceptional sensitivity, with detection limits of 0.075 pg/mL (ECL), 0.095 pg/mL (EIS), and 0.29 pg/mL (colorimetry) for CRP, while demonstrating outstanding anti-interference performance in serum and synovial fluid samples. Beyond providing a precise and reliable method for CRP analysis, this work establishes a new biosensing paradigm that utilizes rationally engineered multifunctional materials for inherently self-validating, multimechanism detection, paving the way for next-generation diagnostic systems capable of high-accuracy analysis in complex real-world samples.